RELMARQA Trademark

Trademark Overview

On Monday, November 18, 2024, a trademark application was filed for RELMARQA with the United States Patent and Trademark Office. The USPTO has given the RELMARQA trademark a serial number of 98858243. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, April 8, 2025. This trademark is owned by Corcept Therapeutics Incorporated. The RELMARQA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations for the treatment of Cushing's syndrome and Cushing's disease; pharmaceutical preparations for the treatment of cancer, liver disorders, oncologic, endocrine, metabolic, cardiovascular, ophthalmic, and gastroenterologic diseases and disorders
relmarqa

General Information

Serial Number98858243
Word MarkRELMARQA
Filing DateMonday, November 18, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, April 8, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 29, 2025

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations for the treatment of Cushing's syndrome and Cushing's disease; pharmaceutical preparations for the treatment of cancer, liver disorders, oncologic, endocrine, metabolic, cardiovascular, ophthalmic, and gastroenterologic diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 18, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCorcept Therapeutics Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025

Trademark Events

Event DateEvent Description
Monday, November 18, 2024NEW APPLICATION ENTERED
Monday, November 18, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 31, 2025ASSIGNED TO EXAMINER
Monday, March 31, 2025APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

relmarqa pharmaceutical disorders treatment preparations diseases cushing endocrine metabolic cardiovascular ophthalmic